Prof. Dr. Ahmet Özdoğan
Thyroid & Parathyroid

Thyroid Ultrasound and TI-RADS Classification

Thyroid ultrasound categorises nodules by the ACR TI-RADS 2017 system into risk categories TR1–TR5; TR4 (≥3 points) and TR5 (≥7 points) nodules are evaluated against size-based biopsy thresholds.

General reading about Thyroid Ultrasound and TI-RADS Classification does not replace a thyroid and parathyroid surgery examination; meaning comes from personal findings. Thyroid ultrasound categorises nodules by the ACR TI-RADS 2017 system into risk categories TR1–TR5; TR4 (≥3 points) and TR5 (≥7 points) nodules are evaluated against size-based biopsy thresholds. Age, expectations, symptom duration, side pattern and previous procedures change the weight of assessment. this term assessment interprets neck examination, the finding nodule behavior, this entry hormone balance, the clinical point vocal fold mobility and the dictionary entry family history together. This entry organizes the this topic details that belong in consultation notes. The first message for this term is that the finding becomes meaningful through history, examination and selected tests: The ACR TI-RADS system assigns points across five feature categories (composition, echogenicity, shape, margin, echogenic foci). This keeps online information from replacing personal diagnosis.

A the finding visit gathers the current complaint, previous treatment experience and patient expectation into one clinical file. The key question is whether examination supports that story or suggests another explanation. this topic review may combine ultrasound findings, this term laboratory results, the finding fine-needle biopsy and this entry laryngoscopic vocal fold assessment when useful. the clinical point decisions weigh nodule size, the dictionary entry ultrasound pattern, this topic lymph-node appearance, this term prior biopsy result and the finding risk profile separately. When this entry is assessed, the short definition, patient wording and objective findings are read together: FNA is recommended for TR5 nodules ≥1 cm, TR4 ≥1.5 cm, and TR3 ≥2.5 cm. Higher-risk possibilities are considered first, then the next clinical step is chosen. Conclusions rely on coherent evidence rather than one isolated finding.

Observation, medication, supportive care, procedures and surgery are treated as stepwise options in this term. Each step is matched with diagnostic certainty and patient safety. the finding planning discusses observation, this entry medical adjustment, the clinical point lobectomy-total thyroidectomy, the dictionary entry parathyroid strategy or this topic neck dissection by findings. Before a care path is chosen for this term, expected benefit, alternatives, recovery, possible complications and the later review plan are discussed in the same visit. The aim is a proportionate decision that preserves function.

Follow-up for the finding varies from patient to patient. Age, overall health, medication, previous operations, comorbidities and functional expectations influence review timing. this entry follow-up reviews calcium balance, the clinical point voice quality, the finding wound healing, this entry pathology results and the clinical point hormone replacement together. Patient counselling for the dictionary entry aims to prepare the right questions without replacing personal diagnosis with online information, recognize safety signals and decide with examination findings. During this topic care, this term care with palpitations, low-calcium symptoms, increasing neck pressure or new voice change is recorded as a warning-sign note.

Assessment of the finding is more efficient when the patient separates what changed, what limits daily life and which symptom may be a warning sign; the final conclusion still depends on personal examination and current findings.

TI-RADS Scoring and Diagnostic Criteria

Composition: cystic/spongiform=0, mixed=1, solid=2 points. Echogenicity: anechoic=0, hyper/isoechoic=1, hypoechoic=2, very hypoechoic=3. Shape: wider-than-tall=0, taller-than-wide=3. Margin: smooth/ill-defined=0, lobulated/irregular=2, extra-thyroidal extension=3. Echogenic foci: none/large comet-tail=0, macrocalcification=1, peripheral calcification=2, microcalcification=3.

TR5 (≥7 points) carries >20% malignancy risk; microcalcifications (OR 6.8), taller-than-wide shape (OR 5.1), and marked hypoechogenicity (OR 4.3) are the strongest independent predictors in meta-analysis (n=10,432). TR4 (3–6 points) confers 5–20% and TR3 (<3 points) <5% malignancy risk.

Biopsy Decision and Next Steps

ACR TI-RADS FNA thresholds: TR5≥1 cm, TR4≥1.5 cm, TR3≥2.5 cm. Biopsy is not recommended for TR1–2. Biopsy is reported per Bethesda system (I–VI). For Bethesda III–IV, repeat FNA or molecular testing (ThyroSeq, Afirma) resolves indeterminate results. In multifocal TR4–5 nodules, both lobes should be sampled independently; the dominant nodule takes priority.

Surveillance: TR3 nodules are followed at 1, 3, and 5 years; TR4–5 with benign FNA are re-imaged at 1 and 2 years. Size increase ≥20% or ≥2 mm, or new suspicious features, triggers repeat biopsy.

When to Seek Care

Urgent thyroid US is indicated for a palpable neck mass, dysphagia, hoarseness, or cervical lymphadenopathy. Incidentally detected nodules (incidentalomas) should be classified by ACR TI-RADS before biopsy decisions. Patients with known thyroid nodules should undergo annual US surveillance under endocrinology or ENT specialist supervision.

Frequently asked questions

What is Thyroid Ultrasound and TI-RADS Classification?
Thyroid ultrasound categorises nodules by the ACR TI-RADS 2017 system into risk categories TR1–TR5; TR4 (≥3 points) and TR5 (≥7 points) nodules are evaluated against size-based biopsy thresholds. General reading about Thyroid Ultrasound and TI-RADS Classification does not replace a thyroid and parathyroid surgery examination; meaning comes from personal findings.
When is Thyroid Ultrasound and TI-RADS Classification clinically important?
A the finding visit gathers the current complaint, previous treatment experience and patient expectation into one clinical file. It is discussed in specialist assessment when neck swelling, nodule follow-up, hormone imbalance, voice change or thyroid surgery planning is involved.
When is ENT assessment relevant for Thyroid Ultrasound and TI-RADS Classification?
ENT assessment becomes relevant if symptoms last more than a few weeks, become one-sided or progressive, or are accompanied by breathing, swallowing, voice, hearing or neck-mass findings.
What information helps assessment of Thyroid Ultrasound and TI-RADS Classification?
It is useful to note when symptoms started, which side is affected, previous operations or treatments, current medication, imaging and test reports, and the effect on daily life. It is discussed in specialist assessment when neck swelling, nodule follow-up, hormone imbalance, voice change or thyroid surgery planning is involved.

Learn more about this procedure

Detailed guide from Prof. Dr. Özdoğan's clinic

View Guide →

References

This glossary entry is for informational purposes only and does not constitute medical advice. Consult a qualified specialist for diagnosis and treatment.

Back to Medical Dictionary
Message on WhatsAppCall